Home › NDC Lookup › RxCUI directory › RxCUI 2673205

Eflornithine 192 MG Oral Tablet [Iwilfin] — RxCUI 2673205

RxNorm drug concept · Semantic branded drug
RxCUI 2673205 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2673205
Official nameEflornithine 192 MG Oral Tablet [Iwilfin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asIwilfin 192 MG Oral Tablet; Iwilfin 192 MG (equivalent to eflornithine HCl 250 MG) Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)490 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Eflornithine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's a great question, and it's a common one. Iwilfin isn't used during the main phase of cancer treatment — it's given afterward. Once your child (or you) has responded well to...
  • What exactly is Iwilfin used for — I thought neuroblastoma treatment was already done?
  • Yes — that's actually built into how Iwilfin is designed. The tablets can be swallowed whole, chewed, or crushed and mixed into soft food or liquid like pudding. So you have real f...
  • Can my child chew or crush the Iwilfin tablet? They have trouble swallowing pills.
📖 Read our full Eflornithine guide →

🕸️ Concept Web — How Eflornithine 192 MG Oral Tablet [Iwilfin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Eflornithine 192 MG Oral Tablet [Iwilfin] RxCUI 2673205

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Eflornithine 569
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Iwilfin 2673200
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Eflornithine Oral Tablet 2673198
    • Eflornithine Oral Product 2673196
    • Eflornithine Pill 2673197
    • Eflornithine Oral Tablet [Iwilfin] 2673204
    • Iwilfin Oral Product 2673202
    • Iwilfin Pill 2673203
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Eflornithine 192 MG Oral Tablet SCD · 2673199
  • Eflornithine 192 MG SCDC · 2673195
  • Eflornithine Oral Tablet SCDF · 2673198
  • Eflornithine Oral Product SCDG · 2673196
  • Eflornithine Pill SCDG · 2673197

Brand-Name Concepts

  • Eflornithine 192 MG [Iwilfin] SBDC · 2673201
  • Eflornithine Oral Tablet [Iwilfin] SBDF · 2673204
  • Iwilfin Oral Product SBDG · 2673202
  • Iwilfin Pill SBDG · 2673203
  • Iwilfin BN · 2673200

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2673205 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
78670-0150-01 1 BOTTLE in 1 CARTON (78670-150-01) / 100 TABLET in 1 BOTTL... iwilfin USWM, LLC 2024-01-15
Observed labelers: USWM, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.